| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | NANOSTRING TECHNOLOGIES INC | 3,959,440 | 60,263,000 | 45.24% | ||
| 2 | Oxford Immunotec Global PLC | 2,153,092 | 21,337,000 | 16.02% | ||
| 3 | SIENTRA INC | 2,730,765 | 18,678,000 | 14.02% | ||
| 4 | Catabasis Pharmaceuticals Inc | 2,752,488 | 13,873,000 | 10.42% | ||
| 5 | VBI Vaccines Inc. | 5,173,013 | 12,157,000 | 9.13% | ||
| 6 | ESSA Pharma | 2,121,212 | 6,894,000 | 5.18% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001012975-16-001176, filed 2016.04.22).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
